Fig. 2From: FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancerFDG uptake before (a) and after (b) immunotherapy. Maximum standardized uptake value (SUVmax) of supraclavicular lymph node and disseminated lesions before and after immunotherapy decreased from 9.8 to no accumulation and 5.9 to 3.4, respectively. Each SUVmax was decreased after six courses of nivolumab treatmentBack to article page